The treatment of prostate cancer local recidive
If there is a renewed increase in PSA after treatment of a prostate carcinoma, appropriate clarifications or examinations, such as MRI and PSMA PET/CT, must be performed in order to distinguish whether it is a local recidive in the box or the prostate itself or a distant recidive in the form of metastases. More than 50% of recidives are local recidives.
In case of local recidive, a variety of treatment alternatives (surgery, conventional radiation, cyberknife, cryotherapy, focused ultrasound (HIFU), brachytherapy) are available. Systemic therapy (anti-hormonal therapy) is preferred when patients are not candidates for invasive surgery due to poor general health or do not consent to invasive surgery. The risks of invasive therapy, such as bleeding, urethral strictures, fistulas, incontinence, and impotence, must be considered and weighed. The indication must be examined very critically, especially in elderly or multimorbid patients.
Cyberknife for the treatment of prostate cancer recidive.
In this article, the possibilities of Cyberknife therapy for prostate cancer recidieves are discussed with our cooperation partners. Also, a patient treated for a recurrent prostate tumor a few years ago describes his personal experience with this therapy and how he fared afterwards.